カテゴリー： Market Monitor Global, 世界, 医療/バイオ

獣医用ウイルスベクターワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Veterinary Viral Vectored Vaccine Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8748 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：77 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Veterinary Viral Vectored Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるの獣医用ウイルスベクターワクチン市場規模と予測を収録しています。・世界の獣医用ウイルスベクターワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の獣医用ウイルスベクターワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の獣医用ウイルスベクターワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アルファヘルペスウイルス（HVT）ベクター」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

獣医用ウイルスベクターワクチンのグローバル主要企業は、Boehringer-Ingelheim、 Cevaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、獣医用ウイルスベクターワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の獣医用ウイルスベクターワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の獣医用ウイルスベクターワクチン市場：タイプ別市場シェア、2022年
・アルファヘルペスウイルス（HVT）ベクター、カナリア痘ベクター、ワクシニアベクター

世界の獣医用ウイルスベクターワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の獣医用ウイルスベクターワクチン市場：用途別市場シェア、2022年
・ペット、鶏、その他

世界の獣医用ウイルスベクターワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の獣医用ウイルスベクターワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における獣医用ウイルスベクターワクチンのグローバル売上、2018年-2023年
・主要企業における獣医用ウイルスベクターワクチンのグローバル売上シェア、2022年
・主要企業における獣医用ウイルスベクターワクチンのグローバル販売量、2018年-2023年
・主要企業における獣医用ウイルスベクターワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Boehringer-Ingelheim、 Ceva

*************************************************************

・調査・分析レポートの概要
獣医用ウイルスベクターワクチン市場の定義
市場セグメント
世界の獣医用ウイルスベクターワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の獣医用ウイルスベクターワクチン市場規模
世界の獣医用ウイルスベクターワクチン市場規模：2022年 VS 2029年
世界の獣医用ウイルスベクターワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの獣医用ウイルスベクターワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の獣医用ウイルスベクターワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アルファヘルペスウイルス（HVT）ベクター、カナリア痘ベクター、ワクシニアベクター
獣医用ウイルスベクターワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：ペット、鶏、その他
獣医用ウイルスベクターワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別獣医用ウイルスベクターワクチン市場規模 2022年と2029年
地域別獣医用ウイルスベクターワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Boehringer-Ingelheim、 Ceva
...

This report aims to provide a comprehensive presentation of the global market for Veterinary Viral Vectored Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Viral Vectored Vaccine. This report contains market size and forecasts of Veterinary Viral Vectored Vaccine in global, including the following market information:
Global Veterinary Viral Vectored Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Viral Vectored Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Veterinary Viral Vectored Vaccine companies in 2022 (%)
The global Veterinary Viral Vectored Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Alphaherpesvirus (HVT) Vector Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Veterinary Viral Vectored Vaccine include Boehringer-Ingelheim and Ceva etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Viral Vectored Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Viral Vectored Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Veterinary Viral Vectored Vaccine Market Segment Percentages, by Type, 2022 (%)
Alphaherpesvirus (HVT) Vector
Canarypox Vector
Vaccinia Vector
Global Veterinary Viral Vectored Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Veterinary Viral Vectored Vaccine Market Segment Percentages, by Application, 2022 (%)
Pet
Chicken
Others
Global Veterinary Viral Vectored Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Veterinary Viral Vectored Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Viral Vectored Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Veterinary Viral Vectored Vaccine revenues share in global market, 2022 (%)
Key companies Veterinary Viral Vectored Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies Veterinary Viral Vectored Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer-Ingelheim
Ceva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Viral Vectored Vaccine, market overview.
Chapter 2: Global Veterinary Viral Vectored Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Viral Vectored Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Viral Vectored Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Viral Vectored Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Veterinary Viral Vectored Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Viral Vectored Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Viral Vectored Vaccine Overall Market Size
2.1 Global Veterinary Viral Vectored Vaccine Market Size: 2022 VS 2029
2.2 Global Veterinary Viral Vectored Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Veterinary Viral Vectored Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Veterinary Viral Vectored Vaccine Players in Global Market
3.2 Top Global Veterinary Viral Vectored Vaccine Companies Ranked by Revenue
3.3 Global Veterinary Viral Vectored Vaccine Revenue by Companies
3.4 Global Veterinary Viral Vectored Vaccine Sales by Companies
3.5 Global Veterinary Viral Vectored Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Veterinary Viral Vectored Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Veterinary Viral Vectored Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Viral Vectored Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Veterinary Viral Vectored Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Veterinary Viral Vectored Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Veterinary Viral Vectored Vaccine Market Size Markets, 2022 & 2029
4.1.2 Alphaherpesvirus (HVT) Vector
4.1.3 Canarypox Vector
4.1.4 Vaccinia Vector
4.2 By Type – Global Veterinary Viral Vectored Vaccine Revenue & Forecasts
4.2.1 By Type – Global Veterinary Viral Vectored Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Veterinary Viral Vectored Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Veterinary Viral Vectored Vaccine Sales & Forecasts
4.3.1 By Type – Global Veterinary Viral Vectored Vaccine Sales, 2018-2023
4.3.2 By Type – Global Veterinary Viral Vectored Vaccine Sales, 2024-2029
4.3.3 By Type – Global Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Veterinary Viral Vectored Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Veterinary Viral Vectored Vaccine Market Size, 2022 & 2029
5.1.2 Pet
5.1.3 Chicken
5.1.4 Others
5.2 By Application – Global Veterinary Viral Vectored Vaccine Revenue & Forecasts
5.2.1 By Application – Global Veterinary Viral Vectored Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Veterinary Viral Vectored Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Veterinary Viral Vectored Vaccine Sales & Forecasts
5.3.1 By Application – Global Veterinary Viral Vectored Vaccine Sales, 2018-2023
5.3.2 By Application – Global Veterinary Viral Vectored Vaccine Sales, 2024-2029
5.3.3 By Application – Global Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Veterinary Viral Vectored Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Veterinary Viral Vectored Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Veterinary Viral Vectored Vaccine Revenue & Forecasts
6.2.1 By Region – Global Veterinary Viral Vectored Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Veterinary Viral Vectored Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Veterinary Viral Vectored Vaccine Sales & Forecasts
6.3.1 By Region – Global Veterinary Viral Vectored Vaccine Sales, 2018-2023
6.3.2 By Region – Global Veterinary Viral Vectored Vaccine Sales, 2024-2029
6.3.3 By Region – Global Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Veterinary Viral Vectored Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Veterinary Viral Vectored Vaccine Sales, 2018-2029
6.4.3 US Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.4.4 Canada Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.4.5 Mexico Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Veterinary Viral Vectored Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Veterinary Viral Vectored Vaccine Sales, 2018-2029
6.5.3 Germany Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.5.4 France Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.5.5 U.K. Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.5.6 Italy Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.5.7 Russia Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.5.9 Benelux Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Veterinary Viral Vectored Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Veterinary Viral Vectored Vaccine Sales, 2018-2029
6.6.3 China Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.6.4 Japan Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.6.5 South Korea Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.6.7 India Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Veterinary Viral Vectored Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Veterinary Viral Vectored Vaccine Sales, 2018-2029
6.7.3 Brazil Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.7.4 Argentina Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Veterinary Viral Vectored Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Veterinary Viral Vectored Vaccine Sales, 2018-2029
6.8.3 Turkey Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.8.4 Israel Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Veterinary Viral Vectored Vaccine Market Size, 2018-2029
6.8.6 UAE Veterinary Viral Vectored Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Boehringer-Ingelheim
7.1.1 Boehringer-Ingelheim Company Summary
7.1.2 Boehringer-Ingelheim Business Overview
7.1.3 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Major Product Offerings
7.1.4 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Boehringer-Ingelheim Key News & Latest Developments
7.2 Ceva
7.2.1 Ceva Company Summary
7.2.2 Ceva Business Overview
7.2.3 Ceva Veterinary Viral Vectored Vaccine Major Product Offerings
7.2.4 Ceva Veterinary Viral Vectored Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Ceva Key News & Latest Developments
8 Global Veterinary Viral Vectored Vaccine Production Capacity, Analysis
8.1 Global Veterinary Viral Vectored Vaccine Production Capacity, 2018-2029
8.2 Veterinary Viral Vectored Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Veterinary Viral Vectored Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Veterinary Viral Vectored Vaccine Supply Chain Analysis
10.1 Veterinary Viral Vectored Vaccine Industry Value Chain
10.2 Veterinary Viral Vectored Vaccine Upstream Market
10.3 Veterinary Viral Vectored Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Veterinary Viral Vectored Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Veterinary Viral Vectored Vaccine in Global Market
Table 2. Top Veterinary Viral Vectored Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Veterinary Viral Vectored Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Veterinary Viral Vectored Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Veterinary Viral Vectored Vaccine Sales by Companies, (Units), 2018-2023
Table 6. Global Veterinary Viral Vectored Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Veterinary Viral Vectored Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Veterinary Viral Vectored Vaccine Product Type
Table 9. List of Global Tier 1 Veterinary Viral Vectored Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Viral Vectored Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Veterinary Viral Vectored Vaccine Sales (Units), 2018-2023
Table 15. By Type - Global Veterinary Viral Vectored Vaccine Sales (Units), 2024-2029
Table 16. By Application – Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Veterinary Viral Vectored Vaccine Sales (Units), 2018-2023
Table 20. By Application - Global Veterinary Viral Vectored Vaccine Sales (Units), 2024-2029
Table 21. By Region – Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Veterinary Viral Vectored Vaccine Sales (Units), 2018-2023
Table 25. By Region - Global Veterinary Viral Vectored Vaccine Sales (Units), 2024-2029
Table 26. By Country - North America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Veterinary Viral Vectored Vaccine Sales, (Units), 2018-2023
Table 29. By Country - North America Veterinary Viral Vectored Vaccine Sales, (Units), 2024-2029
Table 30. By Country - Europe Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Veterinary Viral Vectored Vaccine Sales, (Units), 2018-2023
Table 33. By Country - Europe Veterinary Viral Vectored Vaccine Sales, (Units), 2024-2029
Table 34. By Region - Asia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Veterinary Viral Vectored Vaccine Sales, (Units), 2018-2023
Table 37. By Region - Asia Veterinary Viral Vectored Vaccine Sales, (Units), 2024-2029
Table 38. By Country - South America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Veterinary Viral Vectored Vaccine Sales, (Units), 2018-2023
Table 41. By Country - South America Veterinary Viral Vectored Vaccine Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Sales, (Units), 2024-2029
Table 46. Boehringer-Ingelheim Company Summary
Table 47. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product Offerings
Table 48. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Boehringer-Ingelheim Key News & Latest Developments
Table 50. Ceva Company Summary
Table 51. Ceva Veterinary Viral Vectored Vaccine Product Offerings
Table 52. Ceva Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Ceva Key News & Latest Developments
Table 54. Veterinary Viral Vectored Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 55. Global Veterinary Viral Vectored Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Veterinary Viral Vectored Vaccine Production by Region, 2018-2023 (Units)
Table 57. Global Veterinary Viral Vectored Vaccine Production by Region, 2024-2029 (Units)
Table 58. Veterinary Viral Vectored Vaccine Market Opportunities & Trends in Global Market
Table 59. Veterinary Viral Vectored Vaccine Market Drivers in Global Market
Table 60. Veterinary Viral Vectored Vaccine Market Restraints in Global Market
Table 61. Veterinary Viral Vectored Vaccine Raw Materials
Table 62. Veterinary Viral Vectored Vaccine Raw Materials Suppliers in Global Market
Table 63. Typical Veterinary Viral Vectored Vaccine Downstream
Table 64. Veterinary Viral Vectored Vaccine Downstream Clients in Global Market
Table 65. Veterinary Viral Vectored Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Veterinary Viral Vectored Vaccine Segment by Type in 2022
Figure 2. Veterinary Viral Vectored Vaccine Segment by Application in 2022
Figure 3. Global Veterinary Viral Vectored Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Veterinary Viral Vectored Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Veterinary Viral Vectored Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Veterinary Viral Vectored Vaccine Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Veterinary Viral Vectored Vaccine Revenue in 2022
Figure 9. By Type - Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Veterinary Viral Vectored Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Veterinary Viral Vectored Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 23. US Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 37. China Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Veterinary Viral Vectored Vaccine Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Veterinary Viral Vectored Vaccine by Region, 2022 VS 2029
Figure 54. Veterinary Viral Vectored Vaccine Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 獣医用ウイルスベクターワクチンの世界市場見通し2023年-2029年(Veterinary Viral Vectored Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

獣医用ウイルスベクターワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp